Table 3.

Multimetabolite prediction biomarker models associated with habitual nut intake^a

Model	Dietary nut exposure urinary biomarker	β ± SEE	P	Model	Dietary nut exposure biomarker	β ± SEE	P
A	Urolithin A	−0.033 ± 1.196	0.98	C	Urolithin A glucuronide	2.905 ± 0.676	<0.001
	Urolithin A glucuronide	2.193 ± 1.032	0.034		Hydroxyhippuric acid	3.436 ± 0.894	<0.001
	Urolithin A sulphate	0.088 ± 1.332	0.95		Hydroxyphenylacetic acid	3.263 ± 0.763	<0.001
	Urolithin A sulphoglucuronide	0.011 ± 1.242	0.99		Dimethylglutaric acid	3.452 ± 1.124	<0.001
	Urolithin B	0.240 ± 1.392	0.86
	Urolithin B glucuronide	0.670 ± 1.212	0.58
	Hydroxyhippuric acid	3.453± 0.971	<0.001
	Hydroxyphenylacetic acid	2.887 ± 0.795	<0.001
	Dodecanedioic acid	1.102 ± 0.850	0.19
	Dimethylglutaric acid	2.339 ± 1.220	0.055
	Indole-3-acetic-acid-O-glucuronide	1.834± 0.965	0.057
	Indoxyl sulphate/Indoxylsulphuric acid	0.688 ± 0.564	0.22
	Dihydroxy-benzoxazinone	−0.186 ± 0.881	0.83
B	Urolithin A	1.380 ± 1.319	0.29	D	Urolithin A	1.899 ± 0.914	0.038
	Urolithin A glucuronide	3.023 ± 1.191	0.011		Urolithin A glucuronide	2.578 ± 0.921	0.005
	Urolithin A sulphate	1.811 ± 1.381	0.19
	Urolithin A sulphoglucuronide	−2.163 ± 1.423	0.13
	Urolithin B	−0.917 ± 1.570	0.56
	Urolithin B glucuronide	0.791 ± 1.368	0.56
	Dodecanedioic acid	1.245 ± 0.895	0.16

^aTobit models were used.